These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 16390386

  • 1. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
    Pietropaolo M, Yu S, Libman IM, Pietropaolo SL, Riley K, LaPorte RE, Drash AL, Mazumdar S, Trucco M, Becker DJ.
    Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
    [Abstract] [Full Text] [Related]

  • 2. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E, Jaeger C, Petzoldt R, Seissler J, Scherbaum WA, Federlin K, Bretzel RG.
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [Abstract] [Full Text] [Related]

  • 3. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [Abstract] [Full Text] [Related]

  • 4. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.
    Maclaren N, Lan M, Coutant R, Schatz D, Silverstein J, Muir A, Clare-Salzer M, She JX, Malone J, Crockett S, Schwartz S, Quattrin T, DeSilva M, Vander Vegt P, Notkins A, Krischer J.
    J Autoimmun; 1999 Jun; 12(4):279-87. PubMed ID: 10330299
    [Abstract] [Full Text] [Related]

  • 5. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C, Hatziagelaki E, Stroedter A, Becker F, Scherer S, Petzoldt R, Federlin K, Bretzel RG.
    Exp Clin Endocrinol Diabetes; 1999 Jun; 107(8):496-505. PubMed ID: 10612480
    [Abstract] [Full Text] [Related]

  • 6. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC, Stone N, de Aizpurua H, Rowley MJ, Harrison LC.
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [Abstract] [Full Text] [Related]

  • 7. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
    Decochez K, De Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Weets I, Vandemeulebroucke E, Truyen I, Kaufman L, Schuit FC, Pipeleers DG, Gorus FK, Belgian Diabetes Registry.
    Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
    [Abstract] [Full Text] [Related]

  • 8. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
    Williams AJ, Bingley PJ, Moore WP, Gale EA, ENDIT Screening Group. European Nicotinamide Diabetes Intervention Trial.
    Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
    [Abstract] [Full Text] [Related]

  • 9. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
    Gianani R, Verge CF, Moromisato-Gianani RI, Yu L, Zhang YJ, Pugliese A, Eisenbarth GS.
    J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
    [Abstract] [Full Text] [Related]

  • 10. Combination of autoantibody markers and risk for development of type 1 diabetes: results from a large french cohort of family members.
    Thivolet C, Nicolino M, Monbeig S, Estour B, Halimi S, Robert M, Orgiazzi J, Chatelain P, GRADI study.
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):279-85. PubMed ID: 12442065
    [Abstract] [Full Text] [Related]

  • 11. Multiple antibody status in type 1 diabetic patients and subjects at various risk with islet-cell antibodies.
    Maugendre D, Chaillous L, Rohmer V, Lecomte P, Marechaud R, Saï P, Marre M, Charbonnel B, Allannic H, Delamaire M.
    Diabetes Metab; 1997 Sep; 23(4):320-6. PubMed ID: 9342546
    [Abstract] [Full Text] [Related]

  • 12. Dual-parameter model for prediction of type I diabetes mellitus.
    Eisenbarth GS, Gianani R, Yu L, Pietropaolo M, Verge CF, Chase HP, Redondo MJ, Colman P, Harrison L, Jackson R.
    Proc Assoc Am Physicians; 1998 Sep; 110(2):126-35. PubMed ID: 9542768
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
    Bergerot I, Souchier C, Thivolet C.
    C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
    [Abstract] [Full Text] [Related]

  • 14. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
    Schmidli RS, Colman PG, Harrison LC.
    J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
    [Abstract] [Full Text] [Related]

  • 15. Identification of prediabetes in first-degree relatives at intermediate risk of type I diabetes.
    Truyen I, De Grijse J, Weets I, Kaufman L, Pipeleers L, Nanos N, Decochez K, Hilbrands R, Kaufman JM, Keymeulen B, Mathieu C, Van Gaal L, Pipeleers DG, Gorus FK, Belgian Diabetes Registry.
    Clin Exp Immunol; 2007 Aug; 149(2):243-50. PubMed ID: 17521324
    [Abstract] [Full Text] [Related]

  • 16. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
    Kretowski A, Kowalska I, Peczyńska J, Urban M, Kinalska I.
    Przegl Lek; 2000 Aug; 57(3):143-6. PubMed ID: 10909282
    [Abstract] [Full Text] [Related]

  • 17. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
    Hermann R, Gombos Z, Gyürüs E, Soltész G.
    Orv Hetil; 2003 Feb 23; 144(8):355-60. PubMed ID: 12666382
    [Abstract] [Full Text] [Related]

  • 18. Study of islet cell antibodies as predictive marker of type 1 diabetes.
    Mitrea MC, Cojocaru M.
    Rom J Intern Med; 1998 Feb 23; 36(3-4):261-5. PubMed ID: 10822523
    [Abstract] [Full Text] [Related]

  • 19. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M, Rabl W, Grassl B, Bachmann W, Standl E, Ziegler AG.
    Diabetologia; 1998 May 23; 41(5):536-41. PubMed ID: 9628270
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Seissler J, Amann J, Mauch L, Haubruck H, Wolfahrt S, Bieg S, Richter W, Holl R, Heinze E, Northemann W.
    J Clin Invest; 1993 Sep 23; 92(3):1394-9. PubMed ID: 8376591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.